Volume 75, Issue 3
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645


The costs of mefloquine, chloroquine, doxycycline, primaquine, and atovaquone/proguanil are calculated for various durations of exposure to malaria. The cost is included for detecting glucose 6-phosphate dehydrogenase (G6PD) deficiency before administering primaquine for primary or terminal prophylaxis. For durations of exposure ranging from 3 to 730 days, if no terminal prophylaxis is given, doxycycline (generic) is the least expensive regimen. Compared with doxycycline hyclate, chloroquine costs three to four times more, and primaquine, after screening for G6PD, costs about eight times more. Atovaquone/proguanil is less expensive than mefloquine for a 3-day exposure, but more expensive for 7 or more days. When terminal chemoprophylaxis with primaquine for 14 days is used in addition to doxycycline, mefloquine, chloroquine, or atovaquone/proguanil, primaquine alone is the least expensive regimen for exposures of < 10 days. Thereafter, doxycycline plus 14 days of primaquine is most economical. For subsequent exposures when G6PD status is already known, primaquine alone is the least expensive regimen for up to 9 days of exposure, but doxycycline is less expensive thereafter. In general, generic doxycycline hyclate is the least expensive regimen. Primaquine alone is economically attractive. Mefloquine, doxycyline monohydrate, and atovaquone/proguanil, the most expensive regimens, are similar in cost for a 7-day exposure, but thereafter, atovaquone/proguanil is much more expensive.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. Centers for Disease Control and Prevention, 2005. Health Information for International Travel, 2005–2006. Atlanta, GA: US Department of Health and Human Service, Public Health Service.
  2. Schwartz E, Parise M, Kozarsky P, Cetron M, 2003. Delayed onset of malaria—implications for chemoprophylaxis in travelers. N Engl J Med 349 : 1510–1516. [Google Scholar]
  3. Centers for Disease Control and Prevention, 2006. Malaria surveillance—United States, 2004. MMWR 55 : 23–37. [Google Scholar]
  4. Baird JK, Fryauff DJ, Hoffman SL, 2003. Primaquine for prevention of malaria in travelers. Clin Infect Dis 37 : 1659–1667. [Google Scholar]
  5. Hill DR, Baird JK, Parise ME, Lewis LS, Ryan ET, Magill AJ, 2006. Primaquine: Report from CDC expert meeting on malaria chemoprophylaxis I. Am J Trop Med Hyg 75 : 402–415. [Google Scholar]
  6. 2005. Thomas Fleming, ed. Drug Topics Red Book, 2005. Montvale, NJ: Thompson Physicians Desk Reference.
  7. Schagenhauf P, Tschopp A, Johnson R, Northdruft HD, Beck B, Schwartz E, Herold M, Krebs B, Veit O, Allwinn R, Steffen R, 2003. Tolerability of malaria chemoprophylaxis in non-immune travelers to sub-Saharan Africa: Multicentre, randomized, double blind, four-arm study. BMJ 327 : 1078–1084. [Google Scholar]
  8. Newton JA, Schnepf GA, Wallace MR, Lobel HO, Kennedy CA, Oldfield EC, 1994. Malaria in US Marines returning from Somalia. JAMA 272 : 397–399. [Google Scholar]
  9. Kotwal RS, Wenzel RB, Sterling RA, Porter WD, Jordan NN, Petruccelli BP, 2005. An outbreak of malaria in US Army Rangers returning from Afghanistan. JAMA 293 : 212–216. [Google Scholar]
  10. Taylor WR, White NJ, 2004. Antimalarial drug toxicity: A review. Drug Saf 27 : 25–61. [Google Scholar]
  11. Van Riemsdijk MM, Stureenboom MC, Ditters JM, Tulen JH, Ligthelm RJ, Overbosch D, Stricker BH, 2004. Low body mass index is associated with an increased risk of neuropsychiatric adverse events and concentration impairment in women on mefloquine. Br J Clin Pharmacol 57 : 506–512. [Google Scholar]
  12. Emberger M, Lechner AM, Zelger B, 2003. Stevens-Johnson syndrome associated with Malarone antimalarial prophylaxis. Clin Infect Dis 37 : e5–e7. [Google Scholar]
  13. Farnert A, Lindberg J, Gil P, Swedberg G, Berqvist Y, Thapar MM, Lindegardh N, Berezcky S, Bjorkman A, 2003. Evidence of Plasmodium falciparum malaria resistant to atovaquone and proguanil hydrochloride: case reports. BMJ 326 : 628–629. [Google Scholar]
  14. Kitchener SJ, Nasveld PE, Gregory RM, Edstein MD, 2005. Mefloquine and doxycycline malaria prophylaxis in Australian soldiers in East Timor. Med J Aust 182 : 168–171. [Google Scholar]

Data & Media loading...

  • Received : 19 Dec 2005
  • Accepted : 30 Apr 2006

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error